<html><head><link rel="stylesheet" type="text/css" href="css.css"></head><h1 id="artitle">Moderna Shares the Blueprint for Its Coronavirus Vaccine Trial<br></h1><p id="artcont">The company hopes to earn the trust of the public and of scientists who have clamored for details of its study. By Denise Grady and Katie Thomas The biotech company Moderna released a 135-page document on Thursday that spells out the details of how it is conducting the late-stage trial of its coronavirus vaccine, and how safety and efficacy will be determined. 